Table 2.
Concentrations of the cholesterol subfractions measured by Lipoprint in MS patients and controls. Data are expressed as mean ± SD, in case of non-parametric distribution as median (25th - 75th percentile)
MS (n = 19) | Controls (n = 19) | |
---|---|---|
VLDL (mmol/l) | 0.757 ± 0.328 | 0.595 (0.524–0.847) |
IDL-A (mmol/l) | 0.218 ± 0.105 | 0.216 ± 0.086 |
IDL-B (mmol/l) | 0.259 (0.207–0.310) | 0.233 (0.181–0.284) |
IDL-C (mmol/l) | 0.885 ± 0.243 | 0.834 ± 0.198 |
LDL1 (mmol/l) | 0.361 ± 0.273 | 0.404 ± 0.230 |
LDL2 (mmol/l) | 0.207 (0.000–0.259) | 0.200 ± 0.217 |
LDL3–7 (mmol/l) | 0.000 (0.000–0.052) | 0.000 (0.000–0.039) |
Large HDL (mmol/l) | 0.763 (0.595–0.957) | 0.709 ± 0.271 |
Intermediate HDL (mmol/l) | 0.646 (0.543–0.802) | 0.621 ± 0.113 |
Small HDL (mmol/l) | 0.111 ± 0.085 | 0.090 ± 0.072 |
Total cholesterol (mmol/l) | 4.54 ± 0.95 | 4.07 ± 0.73 |